Genomics applied to the treatment of breast cancer

Archive ouverte

Hamdan, Diaddin | Nguyen, Thi Thuy Nga | Leboeuf, Christophe | Meles, Solveig | Janin, Anne | Bousquet, Guilhem

Edité par CCSD ; Impact journals -

International audience. Breast cancer remains a major health issue in the world with 1.7 million new cases in 2012 worldwide. It is the second cause of death from cancer in western countries. Genomics have started to modify the treatment of breast cancer, and the developments should become more and more significant, especially in the present era of treatment personalization and with the implementation of new technologies. With molecular signatures, genomics enabled a de-escalation of chemotherapy and personalized treatments of localized forms of estrogen-dependent breast cancers. Genomics can also make a real contribution to constitutional genetics, so as to identify mutations in a panel of candidate genes. In this review, we will discuss the contributions of genomics applied to the treatment of breast cancer, whether already validated contributions or possible future applications linked to research data.

Suggestions

Du même auteur

Targeting Cancer Stem Cells to Overcome Chemoresistance

Archive ouverte | Nunes, Toni | CCSD

International audience. Cancers are heterogeneous at the cell level, and the mechanisms leading to cancer heterogeneity could be clonal evolution or cancer stem cells. Cancer stem cells are resistant to most anti-ca...

Targeting Cancer Stem Cells to Overcome Chemoresistance

Archive ouverte | Nunes, Toni | CCSD

International audience. Cancers are heterogeneous at the cell level, and the mechanisms leading to cancer heterogeneity could be clonal evolution or cancer stem cells. Cancer stem cells are resistant to most anti-ca...

Re-exploring immune-related side effects of docetaxel in an observational study: Blood hypereosinophilia

Archive ouverte | Hamdan, Diaddin | CCSD

International audience. Docetaxel is a major anticancer drug that can induce hypersensitivity reactions leading to deleterious treatment interruptions. Blood hypereosinophilia could be a biological sign, potentially...

Chargement des enrichissements...